{"id":76342,"date":"2026-10-19T20:32:11","date_gmt":"2026-10-19T20:32:11","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76342"},"modified":"2026-10-19T20:35:13","modified_gmt":"2026-10-19T20:35:13","slug":"us-analyst-updates-october-19th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/","title":{"rendered":"US Analyst Updates: October 19th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

American analyst outlook currently reflects a selectively optimistic but increasingly cautious market outlook, with price target reductions significantly outnumbering increases. Technology, artificial intelligence, software, and selected financial services attracted favourable upgrades, while healthcare and biotechnology continued to generate interest through new coverage. However, commercial real estate, consumer-related industries, utilities, and certain financial companies faced downgrades and reduced valuations. Overall, analysts appeared increasingly focused on earnings resilience, valuation discipline, and sustainable growth amid continued economic uncertainty.<\/p>\n

Updates (403)<\/strong><\/h3>\n

A. O. Smith (AOS)<\/strong> \u2014 Longbow Research downgraded the stock from Buy to Neutral.<\/p>\n

A. O. Smith (AOS)<\/strong> \u2014 Stifel downgraded the stock from Buy to Hold with a $59.00 price target.<\/p>\n

Aardvark Therapeutics (AARD)<\/strong> \u2014 HC Wainwright maintained its Neutral rating and lowered its price target to $4.00 from $6.00.<\/p>\n

Aardvark Therapeutics (AARD)<\/strong> \u2014 UBS Group set a $4.00 price target.<\/p>\n

Abacus Global Management (ABX)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $10.00 from $12.00.<\/p>\n

ACADIA Pharmaceuticals (ACAD)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating with a $35.00 price target.<\/p>\n

Adagene (ADAG)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $7.00 price target.<\/p>\n

Adagene (ADAG)<\/strong> \u2014 Stifel Nicolaus set a $7.00 price target.<\/p>\n

Adient (ADNT)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $21.00 from $26.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n

AeroVironment (AVAV)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $170.00 from $230.00.<\/p>\n

AGCO (AGCO)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $97.00 from $105.00.<\/p>\n

Agnico Eagle Mines (AEM)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $218.00 from $188.00.<\/p>\n

Agree Realty (ADC)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $79.00 from $83.00.<\/p>\n

Air Canada (ACDVF)<\/strong> \u2014 Jefferies downgraded the stock from Hold to Underperform.<\/p>\n

Alphabet (GOOG)<\/strong> \u2014 KeyCorp set a $410.00 price target.<\/p>\n

Alphabet (GOOGL)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to $410.00 from $435.00.<\/p>\n

Alto Neuroscience (ANRO)<\/strong> \u2014 HC Wainwright maintained its Buy rating and raised its price target to $60.00 from $55.00.<\/p>\n

Amazon.com (AMZN)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $350.00 from $335.00.<\/p>\n

Amazon.com (AMZN)<\/strong> \u2014 Yorkville Ives initiated coverage with a Outperform rating and a $300.00 price target.<\/p>\n

AMC Entertainment (AMC)<\/strong> \u2014 B. Riley Financial maintained its Neutral rating.<\/p>\n

Ameren (AEE)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $109.00 from $117.00.<\/p>\n

American Axle & Manufacturing (DCH)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to $6.00 from $7.00.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $135.00 from $139.00.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 Jefferies Financial Group set a $135.00 price target.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $135.00 from $140.00.<\/p>\n

American Electric Power (AEP)<\/strong> \u2014 UBS Group set a $135.00 price target.<\/p>\n

American Homes 4 Rent (AMH)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $34.00 from $38.00.<\/p>\n

American Water Works (AWK)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $127.00 from $130.00.<\/p>\n

Ameriprise Financial (AMP)<\/strong> \u2014 Bank of America downgraded the stock from Buy to Underperform with a $445.00 price target.<\/p>\n

Amrize (AMRZ)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $40.00 from $55.00.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $145.00 from $159.00.<\/p>\n

Arcutis Biotherapeutics (ARQT)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to $44.00 from $38.00.<\/p>\n

Ares Management (ARES)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $143.00 from $150.00.<\/p>\n

Athabasca Oil (ATHOF)<\/strong> \u2014 Jefferies downgraded the stock from Buy to Hold.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to $280.00 from $165.00.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to $235.00 from $185.00.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 UBS Group set a $280.00 price target.<\/p>\n

Azul (AZUL)<\/strong> \u2014 The Goldman Sachs Group initiated coverage with a Neutral rating and a $8.10 price target.<\/p>\n

Badger Meter (BMI)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $150.00 from $165.00.<\/p>\n

Ball (BALL)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $70.00 from $72.00.<\/p>\n

Baytex Energy (BTE)<\/strong> \u2014 Scotiabank maintained its Outperform rating.<\/p>\n

Beauty Health (SKIN)<\/strong> \u2014 Jefferies Financial Group maintained its Hold rating and raised its price target to $11.00 from $0.85.<\/p>\n

Bicara Therapeutics (BCAX)<\/strong> \u2014 BTIG Research maintained its Buy rating with a $39.00 price target.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to $1,350.00 from $1,300.00.<\/p>\n

Blackstone (BX)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $125.00 from $130.00.<\/p>\n

Blue Owl Capital (OWL)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $12.00 from $13.00.<\/p>\n

Boyd Gaming (BYD)<\/strong> \u2014 Morgan Stanley upgraded the stock from Equal Weight to Overweight and lowered its price target to $83.00 from $89.00.<\/p>\n

Boyd Gaming (BYD)<\/strong> \u2014 Susquehanna upgraded the stock from Neutral to Positive and lowered its price target to $83.00 from $87.00.<\/p>\n

Boyd Gaming (BYD)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $86.00 from $87.00.<\/p>\n

Brainsway (BWAY)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $19.00 price target.<\/p>\n

BridgeBio Pharma (BBIO)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $120.00 from $115.00.<\/p>\n

Bristol Myers Squibb (BMY)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating.<\/p>\n

Brookfield Asset Management (BAM)<\/strong> \u2014 Piper Sandler set lowered its price target to $49.00 from $50.00 with a Neutral rating.<\/p>\n

Brookfield Renewable (BEPC)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $32.00 from $36.00.<\/p>\n

Brookfield Renewable Partners (BEP)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and lowered its price target to $32.00 from $36.00.<\/p>\n

BXP (BXP)<\/strong> \u2014 Piper Sandler downgraded the stock from Overweight to Neutral with a $64.00 price target.<\/p>\n

Camden Property Trust (CPT)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $103.00 from $110.00.<\/p>\n

Cameco (CCJ)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $95.00 from $97.00.<\/p>\n

Camping World (CWH)<\/strong> \u2014 Northcoast Research set a $11.00 price target.<\/p>\n

Canadian Natural Resources (CNQ)<\/strong> \u2014 Scotiabank maintained its Sector Perform rating.<\/p>\n

Cardinal Infrastructure Group (CDNL)<\/strong> \u2014 Truist Financial set a $30.00 price target.<\/p>\n

CareDx (CDNA)<\/strong> \u2014 Canaccord Genuity Group maintained its Buy rating and raised its price target to $80.00 from $65.00.<\/p>\n

CareTrust REIT (CTRE)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $43.00 from $44.00.<\/p>\n

Caris Life Sciences (CAI)<\/strong> \u2014 Canaccord Genuity Group maintained its Hold rating and raised its price target to $30.00 from $22.00.<\/p>\n

Carlyle Group (CG)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $48.00 from $54.00.<\/p>\n

Carter’s (CRI)<\/strong> \u2014 UBS Group maintained its Neutral rating with a $38.00 price target.<\/p>\n

Celcuity (CELC)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Cenovus Energy (CVE)<\/strong> \u2014 Scotiabank maintained its Outperform rating.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $41.00 from $44.00.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $45.00 from $48.00.<\/p>\n

Centerspace (CSR)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $53.00 from $57.00.<\/p>\n

Charles Schwab (SCHW)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $97.00 from $105.00.<\/p>\n

Cheniere Energy (LNG)<\/strong> \u2014 Raymond James Financial maintained its Strong-Buy rating with a $340.00 price target.<\/p>\n

Chesapeake Utilities (CPK)<\/strong> \u2014 Barclays set lowered its price target to $134.00 from $136.00 with a Equal Weight rating.<\/p>\n

Choice Hotels International (CHH)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and raised its price target to $98.00 from $97.00.<\/p>\n

Chord Energy (CHRD)<\/strong> \u2014 Roth Capital maintained its Buy rating with a $165.00 price target.<\/p>\n

Churchill Downs (CHDN)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $120.00 from $117.00.<\/p>\n

Cinemark (CNK)<\/strong> \u2014 B. Riley Financial maintained its Neutral rating.<\/p>\n

Citizens (CIZN)<\/strong> \u2014 Citigroup reiterated coverage.<\/p>\n

Citizens Financial Group (CFG)<\/strong> \u2014 DA Davidson set a $82.00 price target.<\/p>\n

Citizens Financial Group (CFG)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $87.00 from $89.00.<\/p>\n

Citizens Financial Group (CFG)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $74.00 from $79.00.<\/p>\n

Clene (CLNN)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to $11.00 from $10.00.<\/p>\n

Clorox (CLX)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft maintained its Hold rating with a $95.00 price target.<\/p>\n

CMS Energy (CMS)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to $76.00 from $73.00.<\/p>\n

CNH Industrial (CNH)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $14.00 from $12.00.<\/p>\n

CocaCola (KO)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n

Cognizant Technology Solutions (CTSH)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Colgate-Palmolive (CL)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $104.00 from $103.00.<\/p>\n

Comcast (CMCSA)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating with a $31.00 price target.<\/p>\n

Commercial Metals (CMC)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $73.00 from $75.00.<\/p>\n

Commercial Metals (CMC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $84.00 from $88.00.<\/p>\n

Cooper-Standard (CPS)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to $32.00 from $53.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Moffett Nathanson set a $89.00 price target.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Sanford C. Bernstein upgraded the stock from Underperform to Market Perform.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 The Goldman Sachs Group upgraded the stock from Neutral to Buy with a $106.00 price target.<\/p>\n

CorMedix (CRMD)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating with a $15.00 price target.<\/p>\n

Coty (COTY)<\/strong> \u2014 Jefferies Financial Group maintained its Buy rating and raised its price target to $2.95 from $2.40.<\/p>\n

Crescent Biopharma (CBIO)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $36.00 price target.<\/p>\n

Crescent Biopharma (CBIO)<\/strong> \u2014 UBS Group maintained its Buy rating with a $36.00 price target.<\/p>\n

CRH (CRH)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $110.00 from $131.00.<\/p>\n

Crown (CCK)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $126.00 from $127.00.<\/p>\n

Crown Castle (CCI)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating with a $93.00 price target.<\/p>\n

Cullinan Therapeutics (CGEM)<\/strong> \u2014 BTIG Research maintained its Buy rating with a $40.00 price target.<\/p>\n

Cummins (CMI)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $675.00 from $760.00.<\/p>\n

Curtiss-Wright (CW)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to $518.00 from $700.00.<\/p>\n

Cytokinetics (CYTK)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $140.00 price target.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 Sanford C. Bernstein upgraded the stock from Market Perform to Outperform and raised its price target to $350.00 from $237.00.<\/p>\n

Definium Therapeutics (DFTX)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating.<\/p>\n

Disc Medicine (IRON)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to $120.00 from $100.00.<\/p>\n

Disc Medicine (IRON)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to $170.00 from $125.00.<\/p>\n

Disc Medicine (IRON)<\/strong> \u2014 Truist Financial set a $115.00 price target.<\/p>\n

Disc Medicine (IRON)<\/strong> \u2014 Wedbush maintained its Outperform rating.<\/p>\n

Dominion Energy (D)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $65.00 from $69.00.<\/p>\n

Dow (DOW)<\/strong> \u2014 Bank of America upgraded the stock from Underperform to Neutral with a $31.00 price target.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $31.00 from $36.00.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $30.00 from $29.00.<\/p>\n

e.l.f. Beauty (ELF)<\/strong> \u2014 Jefferies Financial Group maintained its Buy rating and raised its price target to $132.00 from $100.00.<\/p>\n

e.l.f. Beauty (ELF)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $130.00 from $106.00.<\/p>\n

Ellington Credit (EARN)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $4.50 from $5.00.<\/p>\n

Emerson Electric (EMR)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to $145.00 from $135.00.<\/p>\n

Enliven Therapeutics (ELVN)<\/strong> \u2014 HC Wainwright maintained its Buy rating and raised its price target to $73.00 from $65.00.<\/p>\n

Entergy (ETR)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $115.00 from $128.00.<\/p>\n

Entrada Therapeutics (TRDA)<\/strong> \u2014 HC Wainwright maintained its Neutral rating.<\/p>\n

Entrada Therapeutics (TRDA)<\/strong> \u2014 UBS Group maintained its Neutral rating.<\/p>\n

EPR Properties (EPR)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $56.00 from $61.00.<\/p>\n

Equifax (EFX)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $185.00 from $210.00.<\/p>\n

Equity Lifestyle Properties (ELS)<\/strong> \u2014 Wells Fargo & Company set lowered its price target to $64.00 from $69.00 with a Equal Weight rating.<\/p>\n

ESAB (ESAB)<\/strong> \u2014 Stifel Nicolaus set a $114.00 price target.<\/p>\n

Essential Properties Realty Trust (EPRT)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $29.00 from $30.00.<\/p>\n

Essential Properties Realty Trust (EPRT)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $30.00 from $36.00.<\/p>\n

Essex Property Trust (ESS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $279.00 from $297.00.<\/p>\n

Estee Lauder Companies (EL)<\/strong> \u2014 Jefferies Financial Group maintained its Hold rating and raised its price target to $120.00 from $100.00.<\/p>\n

Estee Lauder Companies (EL)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $115.00 from $112.00.<\/p>\n

Evergy (EVRG)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $86.00 from $92.00.<\/p>\n

Exagen (XGN)<\/strong> \u2014 Canaccord Genuity Group maintained its Buy rating and raised its price target to $11.00 from $9.00.<\/p>\n

Exelixis (EXEL)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Exelixis (EXEL)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and raised its price target to $65.00 from $55.00.<\/p>\n

Exelon (EXC)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $44.00 from $49.00.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $200.00 from $177.00.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 UBS Group maintained its Buy rating with a $199.00 price target.<\/p>\n

Eyepoint Pharmaceuticals (EYPT)<\/strong> \u2014 Guggenheim downgraded the stock from Buy to Neutral.<\/p>\n

Eyepoint Pharmaceuticals (EYPT)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold with a $1.00 price target.<\/p>\n

Fair Isaac (FICO)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $1,063.00 from $1,344.00.<\/p>\n

First Financial Bankshares (FFIN)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $33.00 from $35.00.<\/p>\n

First Horizon (FHN)<\/strong> \u2014 Truist Financial maintained its Hold rating and raised its price target to $26.00 from $25.00.<\/p>\n

Floor & Decor (FND)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $45.00 from $55.00.<\/p>\n

FMC (FMC)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

FormFactor (FORM)<\/strong> \u2014 B. Riley Financial maintained its Buy rating.<\/p>\n

Fortune Brands Innovations (FBIN)<\/strong> \u2014 Citigroup maintained its Reduce rating.<\/p>\n

Four Corners Property Trust (FCPT)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $22.00 from $26.00.<\/p>\n

Fox Factory (FOXF)<\/strong> \u2014 B. Riley Financial maintained its Neutral rating.<\/p>\n

Fox Factory (FOXF)<\/strong> \u2014 Roth Capital maintained its Neutral rating with a $17.00 price target.<\/p>\n

Fractyl Health (GUTS)<\/strong> \u2014 Craig Hallum set a $5.00 price target.<\/p>\n

Fractyl Health (GUTS)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating with a $4.00 price target.<\/p>\n

Freeport-McMoRan (FCX)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $84.00 from $83.00.<\/p>\n

FrontView REIT (FVR)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $20.00 from $23.00.<\/p>\n

Gaming and Leisure Properties (GLPI)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $40.00 from $43.00.<\/p>\n

GCM Grosvenor (GCMG)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $14.50 from $16.00.<\/p>\n

Gentherm (THRM)<\/strong> \u2014 Stifel Nicolaus set a $48.00 price target.<\/p>\n

Global Payments (GPN)<\/strong> \u2014 KeyBanc upgraded the stock from Sector Weight to Overweight with a $105.00 price target.<\/p>\n

Global Payments (GPN)<\/strong> \u2014 KeyCorp upgraded the stock from Sector Weight to Overweight with a $105.00 price target.<\/p>\n

Global-E Online (GLBE)<\/strong> \u2014 Morgan Stanley upgraded the stock from Equal Weight to Overweight with a $50.00 price target.<\/p>\n

GoDaddy (GDDY)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and raised its price target to $100.00 from $90.00.<\/p>\n

Grab (GRAB)<\/strong> \u2014 Barclays set a $4.00 price target.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and lowered its price target to $9.00 from $10.00.<\/p>\n

Greif (GEF)<\/strong> \u2014 Wells Fargo & Company maintained its Cautious rating and lowered its price target to $88.00 from $90.00.<\/p>\n

H2O America (HTO)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $65.00 from $66.00.<\/p>\n

Hadron Energy (HDRN)<\/strong> \u2014 HC Wainwright initiated coverage with a Buy rating and a $4.50 price target.<\/p>\n

Halliburton (HAL)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $42.00 from $43.00.<\/p>\n

Harmony Biosciences (HRMY)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating with a $50.00 price target.<\/p>\n

Healthcare Realty Trust (HR)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $18.00 from $20.00.<\/p>\n

Healthpeak Properties (DOC)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $19.00 from $22.00.<\/p>\n

Hexcel (HXL)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $97.00 from $110.00.<\/p>\n

Hilton Grand Vacations (HGV)<\/strong> \u2014 Wells Fargo & Company maintained its Cautious rating and lowered its price target to $38.00 from $51.00.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $383.00 from $382.00.<\/p>\n

HIVE Digital Technologies (HIVE)<\/strong> \u2014 Canaccord Genuity Group maintained its Buy rating with a $10.00 price target.<\/p>\n

Hudson Pacific Properties (HPP)<\/strong> \u2014 Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target to $13.00 from $15.00.<\/p>\n

Hyatt Hotels (H)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $189.00 from $184.00.<\/p>\n

IDEAYA Biosciences (IDYA)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

IDEX (IEX)<\/strong> \u2014 Stifel Nicolaus set a $267.00 price target.<\/p>\n

Illumina (ILMN)<\/strong> \u2014 Canaccord Genuity Group maintained its Hold rating and raised its price target to $300.00 from $205.00.<\/p>\n

Imperial Brands (IMBBY)<\/strong> \u2014 Jefferies downgraded the stock from Buy to Hold.<\/p>\n

Independence Realty Trust (IRT)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $18.00 from $19.00.<\/p>\n

Ingersoll Rand (IR)<\/strong> \u2014 Stifel Nicolaus set a $93.00 price target.<\/p>\n

Intel (INTC)<\/strong> \u2014 Citigroup initiated coverage with a Buy ? Outperform rating.<\/p>\n

Intel (INTC)<\/strong> \u2014 JPMorgan Chase & Co. upgraded the stock from Underweight to Neutral with a $85.00 price target.<\/p>\n

Intel (INTC)<\/strong> \u2014 Morgan Stanley set a $85.00 price target.<\/p>\n

Intel (INTC)<\/strong> \u2014 National Bank Financial set a $85.00 price target.<\/p>\n

Intel (INTC)<\/strong> \u2014 Sanford C. Bernstein upgraded the stock from Market Perform to Outperform.<\/p>\n

Intel (INTC)<\/strong> \u2014 Susquehanna upgraded the stock from Neutral to Positive.<\/p>\n

Intel (INTC)<\/strong> \u2014 The Goldman Sachs Group initiated coverage with a Neutral rating.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n

Invitation Home (INVH)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $30.00 from $33.00.<\/p>\n

ITT (ITT)<\/strong> \u2014 Stifel Nicolaus set a $256.00 price target.<\/p>\n

J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 The Goldman Sachs Group maintained its Neutral rating with a $252.00 price target.<\/p>\n

JAN (JAN)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $34.00 from $35.00.<\/p>\n

Janux Therapeutics (JANX)<\/strong> \u2014 HC Wainwright maintained its Buy rating.<\/p>\n

JetBlue Airways (JBLU)<\/strong> \u2014 UBS Group upgraded the stock from Sell to Neutral and lowered its price target to $3.50 from $4.00.<\/p>\n

Jumia Technologies (JMIA)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to $9.00 from $11.00.<\/p>\n

Kinetik (KNTK)<\/strong> \u2014 Jefferies Financial Group maintained its Hold rating and lowered its price target to $54.00 from $56.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $121.00 from $128.00.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and lowered its price target to $70.00 from $105.00.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Negative.<\/p>\n

Ladder Capital (LADR)<\/strong> \u2014 B. Riley Financial maintained its Buy rating.<\/p>\n

Lam Research (LRCX)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft maintained its Buy rating with a $375.00 price target.<\/p>\n

LandBridge (LB)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating with a $91.00 price target.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $55.00 from $61.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $44.00 from $48.00.<\/p>\n

LCI Industries (LCII)<\/strong> \u2014 Stifel downgraded the stock from Buy to Hold with a $80.00 price target.<\/p>\n

LENZ Therapeutics (LENZ)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $5.00 from $7.00.<\/p>\n

LGN (LGN)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $60.00 from $80.00.<\/p>\n

Liberty Energy (LBRT)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $29.00 from $30.00.<\/p>\n

Liftoff Mobile (LFTO)<\/strong> \u2014 Cantor Fitzgerald .<\/p>\n

Lincoln Electric (LECO)<\/strong> \u2014 Stifel Nicolaus set a $271.00 price target.<\/p>\n

Lithium Americas (Argentina) (LAR)<\/strong> \u2014 National Bank Financial maintained its Outperform rating and lowered its price target to $11.00 from $13.00.<\/p>\n

Live Nation Entertainment (LYV)<\/strong> \u2014 BTIG Research maintained its Buy rating with a $215.00 price target.<\/p>\n

Live Nation Entertainment (LYV)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $215.00 from $200.00.<\/p>\n

LTC Properties (LTC)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $43.00 from $42.00.<\/p>\n

lululemon athletica (LULU)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $90.00 from $95.00.<\/p>\n

Lyft (LYFT)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and lowered its price target to $15.00 from $17.00.<\/p>\n

M&T Bank (MTB)<\/strong> \u2014 DA Davidson maintained its Neutral rating and lowered its price target to $258.00 from $262.00.<\/p>\n

M&T Bank (MTB)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $294.00 from $301.00.<\/p>\n

M&T Bank (MTB)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $245.00 from $255.00.<\/p>\n

Madison Air Solutions (MAIR)<\/strong> \u2014 Stifel Nicolaus set a $35.00 price target.<\/p>\n

MannKind (MNKD)<\/strong> \u2014 Chardan Capital initiated coverage with a Buy rating and a $10.00 price target.<\/p>\n

MannKind (MNKD)<\/strong> \u2014 Chardan Capital Markets initiated coverage with a Buy rating and a $10.00 price target.<\/p>\n

ManpowerGroup (MAN)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $58.00 from $63.00.<\/p>\n

Marcus (MCS)<\/strong> \u2014 B. Riley Financial maintained its Neutral rating.<\/p>\n

Marriott International (MAR)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $426.00 from $425.00.<\/p>\n

Marriott Vacations Worldwide (VAC)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and lowered its price target to $100.00 from $101.00.<\/p>\n

Marsh & McLennan Companies (MRSH)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and raised its price target to $201.00 from $186.00.<\/p>\n

Marsh & McLennan Companies (MRSH)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to $200.00 from $190.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $320.00 from $340.00.<\/p>\n

Matador Resources (MTDR)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $71.00 from $77.00.<\/p>\n

Match Group (MTCH)<\/strong> \u2014 Evercore upgraded the stock from Cautious to Outperform with a $53.00 price target.<\/p>\n

Match Group (MTCH)<\/strong> \u2014 Evercore ISI upgraded the stock from In-line to Outperform with a $53.00 price target.<\/p>\n

Maze Therapeutics (MAZE)<\/strong> \u2014 Canaccord Genuity initiated coverage with a Buy rating and a $75.00 price target.<\/p>\n

Maze Therapeutics (MAZE)<\/strong> \u2014 Canaccord Genuity Group initiated coverage with a Buy rating and a $75.00 price target.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n

MDxHealth (MDXH)<\/strong> \u2014 BTIG Research downgraded the stock from Buy to Neutral.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $820.00 from $775.00.<\/p>\n

Methanex (MEOH)<\/strong> \u2014 Canadian Imperial Bank of Commerce maintained its Outperform rating with a $77.00 price target.<\/p>\n

MGM Resorts International (MGM)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to $29.00 from $43.00.<\/p>\n

MGM Resorts International (MGM)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $29.00 from $48.30.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Sanford C. Bernstein maintained its Outperform rating and raised its price target to $662.00 from $660.00.<\/p>\n

Mid-America Apartment Communities (MAA)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $131.00 from $146.00.<\/p>\n

Monster Beverage (MNST)<\/strong> \u2014 Piper Sandler maintained its Overweight rating with a $50.50 price target.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $210.00 from $215.00.<\/p>\n

Natera (NTRA)<\/strong> \u2014 Canaccord Genuity Group maintained its Buy rating and raised its price target to $500.00 from $375.00.<\/p>\n

National Health Investors (NHI)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $68.00 from $78.00.<\/p>\n

National Healthcare Properties (NHP)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $18.00 from $19.00.<\/p>\n

Neptune Insurance (NP)<\/strong> \u2014 Piper Sandler maintained its Overweight rating.<\/p>\n

NETSTREIT (NTST)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to $19.00 from $20.00.<\/p>\n

NETSTREIT (NTST)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $20.00 from $23.00.<\/p>\n

newcleo (NWCL)<\/strong> \u2014 BTIG Research initiated coverage with a Neutral rating.<\/p>\n

Newmark Group (NMRK)<\/strong> \u2014 Piper Sandler downgraded the stock from Overweight to Neutral with a $13.00 price target.<\/p>\n

Newmont (NEM)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $123.00 from $124.00.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 Barclays set lowered its price target to $84.00 from $91.00 with a Equal Weight rating.<\/p>\n

NiSource (NI)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to $44.00 from $45.00.<\/p>\n

NiSource (NI)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to $48.00 from $45.00.<\/p>\n

NNN REIT (NNN)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $43.00 from $47.00.<\/p>\n

Northrim BanCorp (NRIM)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $29.00 from $30.00.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Jefferies Financial Group set a $131.00 price target.<\/p>\n

Nucor (NUE)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $306.00 from $295.00.<\/p>\n

Nuvation Bio (NUVB)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

O-I Glass (OI)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $10.00 from $12.00.<\/p>\n

Occidental Petroleum (OXY)<\/strong> \u2014 Stephens maintained its Overweight rating and raised its price target to $80.00 from $78.00.<\/p>\n

Ocular Therapeutix (OCUL)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating with a $18.00 price target.<\/p>\n

OGE Energy (OGE)<\/strong> \u2014 Barclays downgraded the stock from Overweight to Equal Weight with a $48.00 price target.<\/p>\n

Oklo (OKLO)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $49.00 from $55.00.<\/p>\n

Omega Healthcare Investors (OHI)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $46.00 from $48.00.<\/p>\n

Ondas (ONDS)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Oruka Therapeutics (ORKA)<\/strong> \u2014 BTIG Research maintained its Buy rating with a $151.00 price target.<\/p>\n

Ovintiv (OVV)<\/strong> \u2014 Scotiabank set a $80.00 price target.<\/p>\n

Par Pacific (PARR)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating with a $117.00 price target.<\/p>\n

Park Aerospace (PKE)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Parker-Hannifin (PH)<\/strong> \u2014 Stifel Nicolaus set a $1,002.00 price target.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 Cleveland Research downgraded the stock from Neutral to Underperform.<\/p>\n

PDF Solutions (PDFS)<\/strong> \u2014 DA Davidson maintained its Buy rating and lowered its price target to $68.00 from $74.00.<\/p>\n

Pebblebrook Hotel Trust (PEB)<\/strong> \u2014 Stifel Nicolaus set a $22.00 price target.<\/p>\n

PENN Entertainment (PENN)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $18.00 from $20.00.<\/p>\n

PENN Entertainment (PENN)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to $26.00 from $30.00.<\/p>\n

PENN Entertainment (PENN)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $22.00 from $23.00.<\/p>\n

Phillips 66 (PSX)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating with a $335.00 price target.<\/p>\n

Plains All American Pipeline (PAA)<\/strong> \u2014 Raymond James Financial maintained its Strong-Buy rating with a $28.00 price target.<\/p>\n

Plains GP (PAGP)<\/strong> \u2014 Raymond James Financial maintained its Strong-Buy rating with a $30.00 price target.<\/p>\n

Polaris (PII)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Polaris (PII)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $55.00 from $70.00.<\/p>\n

Pool (POOL)<\/strong> \u2014 Citigroup maintained its Underperform rating.<\/p>\n

Pool (POOL)<\/strong> \u2014 Longbow Research downgraded the stock from Buy to Neutral.<\/p>\n

Primo Brands (PRMB)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft set a $21.00 price target.<\/p>\n

Progressive (PGR)<\/strong> \u2014 UBS Group maintained its Neutral rating with a $238.00 price target.<\/p>\n

Prologis (PLD)<\/strong> \u2014 KeyCorp maintained its Sector Weight rating.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Barclays maintained its Underweight rating and lowered its price target to $94.00 from $96.00.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to $100.00 from $105.00.<\/p>\n

Quantum Computing (QUBT)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating with a $22.00 price target.<\/p>\n

Quest Diagnostics (DGX)<\/strong> \u2014 UBS Group maintained its Neutral rating with a $250.00 price target.<\/p>\n

Quoin Pharmaceuticals (QNRX)<\/strong> \u2014 Canaccord Genuity initiated coverage with a Buy rating and a $18.00 price target.<\/p>\n

Quoin Pharmaceuticals (QNRX)<\/strong> \u2014 Canaccord Genuity Group initiated coverage with a Buy rating and a $18.00 price target.<\/p>\n

Realty Income (O)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to $59.00 from $61.00.<\/p>\n

Realty Income (O)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $59.00 from $64.00.<\/p>\n

Recursion Pharmaceuticals (RXRX)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating with a $8.00 price target.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $59.00 from $61.00.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $78.00 from $77.00.<\/p>\n

Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $865.00 from $854.00.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 Brean Capital upgraded the stock from Neutral to Buy with a $33.00 price target.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 Capital One Financial set a $33.00 price target.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 DA Davidson maintained its Neutral rating and lowered its price target to $31.00 from $32.00.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $32.00 from $34.00.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to $30.00 from $32.00.<\/p>\n

Repligen (RGEN)<\/strong> \u2014 Canaccord Genuity Group maintained its Hold rating and raised its price target to $180.00 from $145.00.<\/p>\n

Resideo (REZI)<\/strong> \u2014 Citizens initiated coverage with a Market Outperform rating and a $22.00 price target.<\/p>\n

Resideo Technologies (REZI)<\/strong> \u2014 Citigroup initiated coverage with a Market Outperform rating.<\/p>\n

Resideo Technologies (REZI)<\/strong> \u2014 Citizens Jmp initiated coverage with a Market Outperform rating and a $22.00 price target.<\/p>\n

Restaurant Brands International (QSR)<\/strong> \u2014 Royal Bank Of Canada maintained its Neutral rating and lowered its price target to $79.00 from $80.00.<\/p>\n

Revolution Medicines (RVMD)<\/strong> \u2014 Truist Financial maintained its Buy rating and raised its price target to $241.00 from $240.00.<\/p>\n

Rigel Pharmaceuticals (RIGL)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $85.00 price target.<\/p>\n

Rollins (ROL)<\/strong> \u2014 Canaccord Genuity Group maintained its Hold rating and lowered its price target to $36.00 from $45.00.<\/p>\n

Rollins (ROL)<\/strong> \u2014 Sanford C. Bernstein maintained its Market Perform rating and lowered its price target to $35.00 from $42.00.<\/p>\n

Rush Street Interactive (RSI)<\/strong> \u2014 Morgan Stanley initiated coverage with a Equal Weight rating and a $22.00 price target.<\/p>\n

Sabra Healthcare REIT (SBRA)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $21.00 from $23.00.<\/p>\n

SEI Investments (SEIC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to $127.00 from $120.00.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 UBS Group set a $165.00 price target.<\/p>\n

SharkNinja (SN)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to $223.00 from $207.00.<\/p>\n

Silence Therapeutics (SLN)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold.<\/p>\n

Silence Therapeutics (SLN)<\/strong> \u2014 William Blair downgraded the stock from Outperform to Market Perform.<\/p>\n

Silgan (SLGN)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $52.00 from $56.00.<\/p>\n

Simmons First National (SFNC)<\/strong> \u2014 DA Davidson maintained its Neutral rating and raised its price target to $25.00 from $24.00.<\/p>\n

Simmons First National (SFNC)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to $25.00 from $26.00.<\/p>\n

Simmons First National (SFNC)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to $27.00 from $26.00.<\/p>\n

Simmons First National (SFNC)<\/strong> \u2014 Robert W. Baird set a $25.00 price target.<\/p>\n

SLB (SLB)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

SLB (SLB)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $63.00 from $64.00.<\/p>\n

Sol-Gel Technologies (SLGL)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $110.00 price target.<\/p>\n

Sonoco Products (SON)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $53.00 from $56.00.<\/p>\n

Southern Copper (SCCO)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to $168.00 from $166.00.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating.<\/p>\n

Sportradar Group (SRAD)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $13.50 from $15.00.<\/p>\n

Sprouts Farmers Market (SFM)<\/strong> \u2014 The Goldman Sachs Group set a $94.00 price target.<\/p>\n

Spyre Therapeutics (SYRE)<\/strong> \u2014 BTIG Research maintained its Buy rating with a $121.00 price target.<\/p>\n

State Street (STT)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $185.00 from $200.00.<\/p>\n

Steel Dynamics (STLD)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $285.00 from $272.00.<\/p>\n

Sun Communities (SUI)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $136.00 from $141.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Barclays upgraded the stock from Negative to Outperform.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 UBS Group set a $360.00 price target.<\/p>\n

The Goldman Sachs Group (GS)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $950.00 from $970.00.<\/p>\n

The PNC Financial Services Group (PNC)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to $248.00 from $252.00.<\/p>\n

TIC Solutions (TIC)<\/strong> \u2014 UBS Group maintained its Buy rating.<\/p>\n

Toast (TOST)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to $38.00 from $39.00.<\/p>\n

Tractor Supply (TSCO)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and raised its price target to $33.00 from $31.00.<\/p>\n

Tractor Supply (TSCO)<\/strong> \u2014 Truist Financial set raised its price target to $33.00 from $32.00 with a Hold rating.<\/p>\n

Tractor Supply (TSCO)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $36.00 from $35.00.<\/p>\n

Transdigm Group (TDG)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $1,300.00 from $1,400.00.<\/p>\n

TransUnion (TRU)<\/strong> \u2014 Mizuho maintained its Neutral rating and lowered its price target to $74.00 from $77.00.<\/p>\n

Travel + Leisure (TNL)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $90.00 from $92.00.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft maintained its Hold rating.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 Truist Financial maintained its Buy rating and raised its price target to $435.00 from $425.00.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 UBS Group maintained its Neutral rating.<\/p>\n

Travelers Companies (TRV)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to $377.00 from $341.00.<\/p>\n

TripAdvisor (TRIP)<\/strong> \u2014 Cantor Fitzgerald maintained its Underweight rating and lowered its price target to $8.00 from $9.00.<\/p>\n

Truist Financial (TFC)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $54.00 from $55.00.<\/p>\n

Truist Financial (TFC)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to $51.00 from $53.00.<\/p>\n

United Dominion Realty Trust (UDR)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $39.00 from $43.00.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 Leerink Partners maintained its Outperform rating and raised its price target to $725.00 from $685.00.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 UBS Group set a $725.00 price target.<\/p>\n

Uranium Royalty (UROY)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $4.50 price target.<\/p>\n

Uranium Royalty (UROY)<\/strong> \u2014 National Bank Financial maintained its Outperform rating and raised its price target to $4.00 from $3.75.<\/p>\n

Urogen Pharma (URGN)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $75.00 price target.<\/p>\n

V.F. (VFC)<\/strong> \u2014 UBS Group maintained its Neutral rating with a $17.00 price target.<\/p>\n

Vale (VALE)<\/strong> \u2014 Scotiabank upgraded the stock from Sector Perform to Sector Outperform with a $16.00 price target.<\/p>\n

Varonis Systems (VRNS)<\/strong> \u2014 Barclays downgraded the stock from Overweight to Equal Weight with a $50.00 price target.<\/p>\n

Veeva Systems (VEEV)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to $360.00 from $315.00.<\/p>\n

Ventas (VTR)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $96.00 from $104.00.<\/p>\n

Veradermics (MANE)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

Veradermics (MANE)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and raised its price target to $172.00 from $164.00.<\/p>\n

Veralto (VLTO)<\/strong> \u2014 Stifel Nicolaus set a $113.00 price target.<\/p>\n

VeriSign (VRSN)<\/strong> \u2014 Wedbush maintained its Outperform rating and raised its price target to $351.00 from $341.00.<\/p>\n

Vermilion Energy (VET)<\/strong> \u2014 Scotiabank maintained its Sector Perform rating.<\/p>\n

VICI Properties (VICI)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to $24.00 from $26.00.<\/p>\n

Victoria’s Secret & Co. (VSXY)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to $104.00 from $101.00.<\/p>\n

Virtus Investment Partners (VRTS)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $146.00 from $172.00.<\/p>\n

Vylor (VYLR)<\/strong> \u2014 Vertical Research downgraded the stock from Buy to Hold with a $74.00 price target.<\/p>\n

W.P. Carey (WPC)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $73.00 from $80.00.<\/p>\n

WaFd (WAFD)<\/strong> \u2014 DA Davidson set a $31.00 price target.<\/p>\n

WaFd (WAFD)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $34.00 from $40.00.<\/p>\n

WaFd (WAFD)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $31.00 from $32.00.<\/p>\n

Watts Water Technologies (WTS)<\/strong> \u2014 Stifel Nicolaus set a $445.00 price target.<\/p>\n

Weatherford International (WFRD)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to $110.00 from $118.00.<\/p>\n

WEC Energy Group (WEC)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $108.00 from $117.00.<\/p>\n

Welltower (WELL)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to $268.00 from $266.00.<\/p>\n

Whirlpool (WHR)<\/strong> \u2014 Longbow Research downgraded the stock from Buy to Neutral.<\/p>\n

Wix.com (WIX)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to $90.00 from $80.00.<\/p>\n

Wynn Resorts (WYNN)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $120.00 from $128.00.<\/p>\n

Wynn Resorts (WYNN)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to $125.00 from $131.00.<\/p>\n

X-Energy (XE)<\/strong> \u2014 Piper Sandler maintained its Underweight rating and lowered its price target to $8.00 from $9.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Stifel Nicolaus set a $141.00 price target.<\/p>\n

Zentalis Pharmaceuticals (ZNTL)<\/strong> \u2014 HC Wainwright maintained its Buy rating with a $10.00 price target.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) American analyst outlook currently reflects a selectively optimistic but increasingly cautious market outlook, with price target reductions significantly outnumbering increases. Technology,…<\/p>\n","protected":false},"author":3,"featured_media":76345,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76342","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nUS Analyst Updates: October 19th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US Analyst Updates: October 19th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American analyst outlook currently reflects a selectively optimistic but increasingly cautious market outlook, with price target reductions significantly outnumbering increases. Technology,…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-19T20:32:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-19T20:35:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/10\/Analyst-Update_-Tech-Market-Momentum.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"29 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"US Analyst Updates: October 19th, 2026\",\"datePublished\":\"2026-10-19T20:32:11+00:00\",\"dateModified\":\"2026-10-19T20:35:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/\"},\"wordCount\":5961,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/\",\"name\":\"US Analyst Updates: October 19th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-19T20:32:11+00:00\",\"dateModified\":\"2026-10-19T20:35:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"US Analyst Updates: October 19th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"US Analyst Updates: October 19th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/","og_locale":"en_US","og_type":"article","og_title":"US Analyst Updates: October 19th, 2026","og_description":"Analyst Ratings (USA) American analyst outlook currently reflects a selectively optimistic but increasingly cautious market outlook, with price target reductions significantly outnumbering increases. Technology,…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-19T20:32:11+00:00","article_modified_time":"2026-10-19T20:35:13+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/10\/Analyst-Update_-Tech-Market-Momentum.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"29 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"US Analyst Updates: October 19th, 2026","datePublished":"2026-10-19T20:32:11+00:00","dateModified":"2026-10-19T20:35:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/"},"wordCount":5961,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/","name":"US Analyst Updates: October 19th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-19T20:32:11+00:00","dateModified":"2026-10-19T20:35:13+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/us-analyst-updates-october-19th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"US Analyst Updates: October 19th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76342"}],"version-history":[{"count":7,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76342\/revisions"}],"predecessor-version":[{"id":76351,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76342\/revisions\/76351"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/76345"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}